Early trial tests new drug mixes to shrink tumors before surgery
NCT ID NCT05459129
Summary
This early-phase study tested different combinations of immunotherapy and chemotherapy drugs in patients with advanced head and neck cancer that could be surgically removed. The goal was to see if these treatments given before surgery could shrink or even eliminate the tumor. The trial was small, enrolling only 12 patients, and ended early, so no firm conclusions could be drawn about which combination worked best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
City of Hope
Duarte, California, 91010, United States
-
Hadassah University Hospital - Ein Kerem
Jerusaelm, 9112001, Israel
-
Severance Hospital - Yonsei Cancer Center
Seoul, 03722, South Korea
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.